ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.60
0.00%
US Tech 100
19,430.00
0.14%
S&P 500
5,473.23
0.77%
US Dollar vs CAD
1.37552
0.30%
Bitcoin
65,437.84
-1.58%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Newellis Inc (NUWE)

  7. Newellis Inc (NUWE) News

NUWE Newellis Inc

0.1859
0.0009 (0.49%)
Pre Market
Last Updated: 06:24:36
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Newellis Inc NUWE NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.0009 0.49% 0.1859 06:24:36
Open Price Low Price High Price Close Price Previous Close
0.185
more quote information »

Recent News

Date Time Source Heading
6/10/202415:15EDGAR2Form 8-K - Current report
6/06/202408:15EDGAR2Form 8-K - Current report
6/06/202408:00GLOBENuwellis and DaVita Extend Supply and Collaboration..
5/29/202410:54EDGAR2Form SD - Specialized disclosure report
5/17/202416:22EDGAR2Form ARS - Annual Report to Security Holders
5/17/202416:20EDGAR2Form DEFR14A - Revised definitive proxy soliciting materials
5/14/202408:00GLOBENuwellis Announces Expansion of Ultrafiltration Program to..
5/09/202408:00GLOBENuwellis Announces Purchase Agreement with a 50 Hospital..
5/08/202416:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/08/202416:26EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
5/07/202407:00GLOBENuwellis, Inc. Announces First Quarter 2024 Financial..
5/02/202408:00GLOBENuwellis Receives USPTO Notice of Patent Allowance for..
4/30/202417:09GLOBENuwellis Announces Closing of $2.7 Million Public Offering
4/30/202415:41GLOBENuwellis, Inc. To Report First Quarter 2024 Financial..
4/26/202408:17GLOBENuwellis Announces Pricing of $2.7 Million Public Offering
4/09/202408:00GLOBENuwellis Announces Launch of Ultrafiltration Therapy Using..
3/11/202416:08EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/07/202408:08GLOBELate-Breaking Data Highlighting Benefits of Ultrafiltration..
3/06/202411:02EDGAR2Form 8-K - Current report
3/05/202407:00GLOBENuwellis, Inc. Announces Fourth Quarter and Full Year 2023..
3/05/202405:05IHMARKETNEWSU.S. Futures Dip, Crude Oil Fluctuates
2/27/202408:00GLOBENuwellis, Inc. To Report Fourth Quarter and Full Year 2023..
2/22/202406:58GLOBENuwellis’ Distribution Partner, SeaStar Medical, Receives..
2/20/202416:06GLOBENuwellis, Inc. Reports Inducement Grants Under Nasdaq..
2/20/202407:42GLOBENuwellis to Announce Late-Breaking Clinical Data and Host..
2/08/202416:19EDGAR2Form S-1/A - General form for registration of securities..
2/06/202408:07EDGAR2Form 8-K - Current report
2/06/202408:00GLOBENew Case Series Demonstrates Potential of Aquadex Therapy..
1/09/202416:30EDGAR2Form 8-K/A - Current report: [Amend]
1/08/202408:24EDGAR2Form 8-K - Current report
1/04/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202414:05GLOBENuwellis Receives FDA Clearance for an Additional Dual Lumen..
12/13/202315:05EDGAR2Form 8-K - Current report
11/28/202307:00GLOBENew Real-World Data Highlight the Clinical Benefits of..
11/14/202315:30GLOBENuwellis, Inc. Reports Inducement Grants Under Nasdaq..
11/07/202309:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/202307:15EDGAR2Form 8-K - Current report
11/07/202307:00GLOBENuwellis, Inc. Announces Third Quarter 2023 Financial..
11/01/202315:15EDGAR2Form 8-K - Current report
11/01/202307:00GLOBENuwellis Announces Board of Directors Transition
10/31/202307:00GLOBENuwellis’ Strategic Partner, SeaStar Medical, Receives FDA..
10/18/202315:15GLOBENuwellis, Inc. To Announce Third Quarter 2023 Financial..
10/17/202315:30EDGAR2Form 8-K - Current report
10/17/202315:15GLOBENuwellis Announces Closing of $2.25 Million Public Offering..
10/13/202307:30GLOBENuwellis Announces Pricing of $2.25 Million Public Offering..
10/10/202307:30EDGAR2Form 8-K - Current report
10/10/202307:00GLOBENuwellis Provides Regulatory Update on SeaStar Medical’s..
10/06/202315:50EDGAR2Form POS462C - Post-effective amendment to registration..
10/05/202308:27EDGAR2Form AW - Amendment Withdrawal Request
10/04/202316:29EDGAR2Form POS AM - Post-Effective amendments for registration..

Your Recent History

NASDAQ
NUWE
Newellis
COIN
THCETH
EU
SPIAB
Spie SA 2.625% until 18/...
TSX
2840
Daiwa Asset Management
GATE
ICONSUSDT
$ICONS Token
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved